These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27761802)
41. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma. Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673 [TBL] [Abstract][Full Text] [Related]
42. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer. Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111 [TBL] [Abstract][Full Text] [Related]
43. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608 [TBL] [Abstract][Full Text] [Related]
44. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer. Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310 [TBL] [Abstract][Full Text] [Related]
45. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance]. Yu Z; Yi S; Zhang Y; Li Z; Qiu L Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349 [TBL] [Abstract][Full Text] [Related]
46. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571 [TBL] [Abstract][Full Text] [Related]
47. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma. Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587 [TBL] [Abstract][Full Text] [Related]
48. Promoter methylation, mRNA expression of goat tumor‑associated genes and mRNA expression of DNA methyltransferase in enzootic nasal tumors. Quan Z; Ye N; Hao Z; Wen C; Liao H; Zhang M; Luo L; Cao S; Wen X; Wu R; Yan Q Mol Med Rep; 2015 Oct; 12(4):6275-85. PubMed ID: 26252527 [TBL] [Abstract][Full Text] [Related]
49. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592 [TBL] [Abstract][Full Text] [Related]
51. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921 [TBL] [Abstract][Full Text] [Related]
52. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424 [TBL] [Abstract][Full Text] [Related]
53. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398 [TBL] [Abstract][Full Text] [Related]
54. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065 [TBL] [Abstract][Full Text] [Related]
55. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study. Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631 [TBL] [Abstract][Full Text] [Related]
56. Global analysis of DNA methylation changes during progression of oral cancer. Towle R; Truong D; Hogg K; Robinson WP; Poh CF; Garnis C Oral Oncol; 2013 Nov; 49(11):1033-42. PubMed ID: 24035722 [TBL] [Abstract][Full Text] [Related]
57. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer. Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082 [TBL] [Abstract][Full Text] [Related]
58. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712 [TBL] [Abstract][Full Text] [Related]
59. Hypermethylation of IFN-γ in oral cancer tissues. Tian S; Jiang C; Liu X; Xu S; Zhang Z; Chen H; Zhang Y; Liu Y; Ma D Clin Oral Investig; 2017 Nov; 21(8):2535-2542. PubMed ID: 28091876 [TBL] [Abstract][Full Text] [Related]
60. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2. Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]